Product correctly added to cart.

discount label
(R)-Cetirizine-d4 dihydrochloride
View 3D

Biosynth logo

(R)-Cetirizine-d4 dihydrochloride

CAS: 1133210-23-7

Ref. 3D-IVB21023

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 25 Jun 2024

Product Information

Name:
(R)-Cetirizine-d4 dihydrochloride
Description:

(R)-Cetirizine-d4 dihydrochloride is an analog of the antihistamine drug cetirizine that has been shown to have potential anticancer properties. It has been found to induce apoptosis in cancer cells and inhibit the activity of kinases, which are enzymes that play a critical role in cell signaling pathways. (R)-Cetirizine-d4 dihydrochloride has been tested against a variety of cancer types, including Chinese hamster ovary and human tumor cell lines. This drug also inhibits amphetamine-induced hyperactivity in mice, suggesting a potential use in treating addiction. Additionally, (R)-Cetirizine-d4 dihydrochloride is excreted primarily through urine and may be used as a kinase inhibitor for research purposes.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
388.9 g/mol
Formula:
C21H25ClN2O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IVB21023 (R)-Cetirizine-d4 dihydrochloride

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".